Feinstein Institute Researcher Wins Award for Autism Research

The INSAR's Young Investigator Award recognizes the best Autism-related empirical research studies conducted by up-and-coming scientists who received their PhD or MD in the past seven years and whose papers were published or in press during 2016. Dr. Brimberg's paper titled, "Caspr2-reactive Antibody Cloned from a Mother of an ASD Child Mediates an ASD-like Phenotype in Mice," co-authored by Dr. Brimberg and Simone Mader, PhD, postdoctoral fellow at the Feinstein Institute, found that exposure to a mother's brain-reactive antibodies while the fetus is in the womb could lead to a higher risk for developing an Autism Spectrum Disorder (ASD), particularly in males. These findings could lead to potential diagnostic and preventative strategies for Autism.

"The Feinstein Institute attracts leading investigators at all stages of their careers with a goal to invent new cures," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute. "We congratulate Dr. Brimberg for receiving this distinction early in her career, and we are thrilled that she is continuing our tradition of making a positive impact on health care through research."

About the Feinstein Institute
The Feinstein Institute for Medical Research is the research arm of Northwell Health, the largest healthcare provider in New York. Home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities, the 3,500 researchers and staff of the Feinstein are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we empower imagination and pioneer discovery, visit FeinsteinInstitute.org

SOURCE Feinstein Institute for Medical Research

Related Links

http://www.feinsteininstitute.org/